Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence - Authors' reply

Affiliations

• ¹ Oregon Health & Science University, Portland, OR, USA. Electronic address: fleseriu@ohsu.edu.
• ² Aix Marseille Université, Marseille Medical Genetics, INSERM, Marseille, France; Assistance Publique Hopitaux de Marseille, Department of Endocrinology, La Conception Hospital, Marseille, France.
• ³ Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
• ⁴ San Raffaele Vita-Salute University, Milan, Italy.
• ⁵ Centre Hospitalier de l'Université de Montréal, QC, Canada.
• ⁶ Cedars-Sinai Medical Center, Los Angeles, CA, USA.
• ⁷ University of Sheffield, Sheffield, UK.
• ⁸ Università Federico II di Napoli, Naples, Italy.
• ⁹ Department of Medicine IV, University Hospital of LMU, Ludwig-Maximilians-Universität, Munich, Germany.
• ¹⁰ Neuroendocrine & Pituitary Tumor Clinical Center, Massachusetts General Hospital, Boston, MA, USA.